Cargando…
H(2)O(2)-responsive and plaque-penetrating nanoplatform for mTOR gene silencing with robust anti-atherosclerosis efficacy
The mammalian target of rapamycin (mTOR) that controls autophagy and lipid metabolism is pivotal for atherosclerosis initiation and progression. Although blocking the mTOR function with rapamycin and its analogs may stimulate autophagy and consequently attenuate lipid storage and atherosclerotic les...
Autores principales: | Gao, Wen, Zhao, Yujie, Li, Xiang, Sun, Yuhui, Cai, Michelle, Cao, Wenhua, Liu, Zhenhua, Tong, Lili, Cui, Guanwei, Tang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868311/ https://www.ncbi.nlm.nih.gov/pubmed/29629115 http://dx.doi.org/10.1039/c7sc03582a |
Ejemplares similares
-
Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis
por: Gao, Wen, et al.
Publicado: (2018) -
Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
por: Chen, Qinjun, et al.
Publicado: (2020) -
Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
por: Wang, Qi, et al.
Publicado: (2021) -
Penetration Enhancing of an Erythrocyte-Mimicking Nanoplatform via Papaverine for Radiosensitization
por: Zhang, Jinrui, et al.
Publicado: (2021) -
Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis
por: Poznyak, Anastasia V., et al.
Publicado: (2022)